Gill R F, Abastado J P, Wei W Z
Department of Immunology, Michigan Cancer Foundation, Detroit 48201.
J Immunol Methods. 1994 Dec 2;176(2):245-53. doi: 10.1016/0022-1759(94)90318-2.
Most peptides with putative MHC I restricted sequence motifs do not bind to the corresponding MHC I nor induce cytolytic T cells. There exist additional constraints which limit peptide binding and immunogenicity. To identify immunogenic peptides in novel protein sequences, it will be necessary to first evaluate peptide binding to MHC I. In this study, a soluble single chain fusion protein SC-Kd was used to evaluate potential Kd binding peptides from the sequences of mouse mammary tumor virus gag and env proteins. A total of 27 peptides were identified which displayed the reported Kd restricted motif. Of the 27 peptides, six demonstrated strong to moderate binding to SC-Kd. The strongest binding peptides expressed tyrosine or phenylalanine at position 2 and leucine at the C-terminus. The capability of MMTV peptides to induce CTL corresponds to their SC-Kd binding activity. Of the six peptides that demonstrated moderate to strong binding, five induced CTL in BALB/c mice. These peptides induced CTL after 1-3 in vivo immunizations followed by 5 day in vitro stimulation. Furthermore, a single in vitro stimulation of naive lymphocytes with strong-binding G425 was sufficient to induce significant CTL activity. Weak or non-binding peptides did not induce CTL. Therefore, peptide binding to SC-Kd is a predictive indicator of CTL inducing activity.
大多数具有假定的MHC I限制性序列基序的肽既不与相应的MHC I结合,也不诱导细胞毒性T细胞。还存在其他限制肽结合和免疫原性的因素。为了在新的蛋白质序列中鉴定免疫原性肽,首先有必要评估肽与MHC I的结合情况。在本研究中,使用可溶性单链融合蛋白SC-Kd来评估来自小鼠乳腺肿瘤病毒gag和env蛋白序列的潜在Kd结合肽。共鉴定出27种显示出报道的Kd限制性基序的肽。在这27种肽中,有6种与SC-Kd表现出强到中等程度的结合。结合最强的肽在第2位表达酪氨酸或苯丙氨酸,在C末端表达亮氨酸。MMTV肽诱导CTL的能力与其SC-Kd结合活性相对应。在表现出中等至强结合的6种肽中,有5种在BALB/c小鼠中诱导了CTL。这些肽在1-3次体内免疫后,再经过5天的体外刺激诱导出CTL。此外,用强结合性的G425对未活化的淋巴细胞进行单次体外刺激就足以诱导出显著的CTL活性。弱结合或不结合的肽不诱导CTL。因此,肽与SC-Kd的结合是CTL诱导活性的预测指标。